your Hometown connection SEPTEMBER 28, 2018 | WEBSTER-PENFIELD-ONTARIO | 585.265.3620 | GVPENNYSAVER.COM MA1801573-1
Healthy volunteers are needed for a study of an investigational vaccine A clinical research study to evaluate an investigational vaccine against diseases caused by respiratory syncytial virus (RSV) is now accepting study participants. Respiratory syncytial virus (RSV) is a common virus that causes lower respiratory infections. Most people recover quickly from these infections, but infants and young children, older adults and anyone with a compromised immune system may be at greater risk for more severe infections.
Eligible participants must be: • Generally healthy men or women, ages 18 to 85, • Willing and able to follow a study treatment plan of scheduled study visits, lab tests and other study procedures for the duration of the study, approximately 12 months. You may not be eligible if you have some preexisting conditions, including HIV, hepatitis Band C viruses. Eligible participants will receive study-related medical care and the investigational vaccine at no cost while enrolled in the study. Participation is voluntary and you may leave the study at any time.
Exp. 10/25/18
Exp. 10/25/18
For more information, please contact: University of Rochester Medical Center Vaccine Research Unit 585-273-3990 or email us at: Vaccine_Research_Unit@urmc.rochester.edu
Exp. 10/25/18
Exp. 10/25/18
Exp. 10/25/18